SCHEMBL1464061

SCHEMBL1464061

CC(C)(C)C(C)(c1ccc(Br)cc1)N(CCCC(O)c1ccccc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RIPK1 Q13546 1/20 0.40
LMNA P02545 3/20 0.36
ALDH1A1 P00352 1/20 0.36
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
CNR1 P21554 2/20 0.34
HTT P42858 1/20 0.34
ATM Q13315 1/20 0.34
APEX1 P27695 1/20 0.34
PDE4A P27815 1/20 0.34
HTR2A P28223 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
HTR2B P41595 1/20 0.34
BLM P54132 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1464040 0.84 IGF1R (0.36) MEN1KMT2AALDH1A1NPSR1HTT
SCHEMBL3206771 0.74 MEN1 (0.44) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL3206769 0.74 MEN1 (0.44) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL3206781 0.74 MEN1 (0.44) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL1464059 0.73 RIPK1 (0.43) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL1529441 0.72 RIPK1 (0.53) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL5065804 0.72 RIPK1 (0.53) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL5069200 0.72 RIPK1 (0.53) MEN1KMT2ARIPK1LMNAALDH1A1
SCHEMBL9507007 0.70 RIPK1 (0.47) RIPK1LMNAALDH1A1KDM4EATM
SCHEMBL9962943 0.70 MEN1 (0.42) MEN1KMT2ARIPK1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071139-A1 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 VITAE PHARMACEUTICALS, INC. 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071139-A1 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSD17B1, HSD3B1 MEN1 730/4885KMT2A 4307/4885RIPK1 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.